Zobrazeno 1 - 10
of 374
pro vyhledávání: '"Toru, Matsunaga"'
Autor:
Takeshi Fujimori, Yuki Shibayama, Takahiro Kanda, Kenta Suzuki, Daisuke Ogawa, Ryou Ishikawa, Kyuichi Kadota, Toru Matsunaga, Takashi Tamiya, Akira Nishiyama, Keisuke Miyake
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Glioblastoma is characterized by a strong self-renewal potential and poor differentiated state. We have reported previously that the (pro)renin receptor [(P)RR] is a potential target for glioma therapy by silencing the (P)RR gene. Here, we h
Externí odkaz:
https://doaj.org/article/dbe80dc1bdf846a9bc71f3dc0d24b1d9
Autor:
Mari Yamasaki, Rikiya Taoka, Kazuya Katakura, Toru Matsunaga, Naoya Kani, Tomoko Honda, Satoshi Harada, Yoichiro Tohi, Yuki Matsuoka, Takuma Kato, Homare Okazoe, Hiroyuki Tsunemori, Nobufumi Ueda, Reiji Haba, Mikio Sugimoto
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background The Paris System (TPS) for reporting urinary cytology differs from conventional systems (CS) in that it focuses on the diagnosis of high-grade urothelial carcinoma (HGUC). This study investigated the impact of TPS implementation o
Externí odkaz:
https://doaj.org/article/9106d80355d04caab1bebd3a96a0344b
Autor:
Kaori Enomoto, Toru Matsunaga, Tadashi Sofue, Akihiro Nakamura, Eiichiro Hirakawa, Emi Ibuki, Reiji Haba, Shingo Kamoshida, Hiroyuki Ohsaki
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8846-8853 (2021)
Abstract Background p53 immunostaining is routinely used as a surrogate marker for TP53 mutational status. In urine cytology, p53 immunocytochemistry is reportedly useful in detecting urothelial carcinoma cells as well as in improving the detection s
Externí odkaz:
https://doaj.org/article/1b8b4231fdc445a4990afc9c5b7c14df
Autor:
Bi Zhicheng, Hossain, Akram, Akumwami, Steeve, Toru Matsunaga, Sikder, Md. Mamun, Kento Kitada, Rahman, Asadur, Masaaki Tokuda, Akira Nishiyama
Publikováno v:
Japanese Journal of Food Chemistry & Safety; 2024, Vol. 31 Issue 1, p21-30, 10p
Autor:
Mizuki Kita, Kazutaka Kanai, Hisaya K. Ono, Yuya Otaka, Daiki Okada, Noriaki Nagai, Rina Kudo, Yohei Yamashita, Shiori Hino, Toru Matsunaga, Kazuki Tajima
Publikováno v:
Veterinary Sciences, Vol 8, Iss 10, p 238 (2021)
This study aimed to compare the in vitro and in vivo retention, bacterial adhesion, and biofilm formation between anionic and zwitterionic bandage contact lenses (BCLs) in healthy canines. BCL retention and tolerance were evaluated in 10 healthy cani
Externí odkaz:
https://doaj.org/article/34f809536d8642328b3883070e4f93bf
Autor:
Takahiro Minami, Waka Ishida, Tatsuma Kishimoto, Isana Nakajima, Shiori Hino, Ritsuko Arai, Toru Matsunaga, Atsuki Fukushima, Satoru Yamagami
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210362 (2019)
A number of drug-releasing contact lenses are currently being studied to address issues inherent in eye drops as a drug delivery method. In this study, we developed epinastine hydrochloride-releasing daily soft contact lenses for treatment of allergi
Externí odkaz:
https://doaj.org/article/59f7ff0ecded4ee09bfcfc0b837b5c2f
Autor:
Chisa Murazawa, Nozomi Hashimoto, Kana Kuraishi, Mutsumi Motoyama, Shin-Ichiro Hashimoto, Mayumi Ikeuchi, Shoko Norimura, Toru Matsunaga, Koji Teramoto, Reiji Haba, Noriko Abe, Toshiki Yajima, Keiichi Kontani
Publikováno v:
Oncology Letters. 25
Autor:
Kosuke Inoue, Reiji Haba, Kana Kiyonaga, Toru Matsunaga, Seiko Kagawa, Toshitetsu Hayashi, Ryou Ishikawa
Publikováno v:
Acta Cytologica.
Introduction: This study aimed to clarify the diagnostic structural features in cytology specimens that are useful in subtyping non-small cell lung carcinoma (NSCLC) into adenocarcinoma (ADC) and squamous cell carcinoma (SQCC). Methods: Cytology spec
Autor:
Hiroyuki Ohsaki, Toru Matsunaga, Taishi Fujita, Yasunori Tokuhara, Shingo Kamoshida, Tadashi Sofue
Publikováno v:
Bio-Protocol, Vol 8, Iss 9 (2018)
In glomerular disease, podocytes and parietal epithelial cells (PECs) are shed in the urine. Therefore, urinary podocytes and PECs are noninvasive biomarkers of glomerular disease. The purpose of this protocol is to employ immunocytochemistry to dete
Externí odkaz:
https://doaj.org/article/806a5df262f248d68498eff0042528a8
Autor:
Toru Matsunaga, Eiichiro Hirakawa, Shingo Kamoshida, Emi Ibuki, Kaori Enomoto, Akihiro Nakamura, Tadashi Sofue, Reiji Haba, Hiroyuki Ohsaki
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8846-8853 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8846-8853 (2021)
Background p53 immunostaining is routinely used as a surrogate marker for TP53 mutational status. In urine cytology, p53 immunocytochemistry is reportedly useful in detecting urothelial carcinoma cells as well as in improving the detection sensitivit